Company intelligence / Profile preview

Bio-Physics Pharma

Princeton, New Jersey, United States

Ownership: Private
Development stage: Other

Overview

Bio-Physics Pharma was a specialty pharmaceutical company focused on developing improved formulations of existing drugs using proprietary physical-chemical technologies. The company primarily targeted the development of topical and systemic treatments for pain and inflammatory conditions. Its lead efforts involved enhancing the delivery and efficacy of non-steroidal anti-inflammatory drugs (NSAIDs). However, the company is no longer active and its development programs have ceased.

Therapeutic areas: ImmunologyNeurology
Modalities: Small molecule
Industry: Biotech

Beyond the preview

Go deeper on Bio-Physics Pharma.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Bio-Physics Pharma.

Explore the full profile